These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5312212)

  • 21. Pharmacokinetic study of intravenous rifampicin.
    Nitti V; Virgilio R; Patricolo MR; Iuliano A
    Chemotherapy; 1977; 23(1):1-6. PubMed ID: 832508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma and saliva concentrations of rifampicin in man after oral administration.
    Orisakwe OE; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):45-9. PubMed ID: 9239804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion of rifampicin and its metabolites as an index of rifampicin blood levels.
    Wardell WM; McQueen EG
    N Z Med J; 1970 Dec; 72(463):393-6. PubMed ID: 5278257
    [No Abstract]   [Full Text] [Related]  

  • 24. [Developement of serum and urine concentrations of rifampicin during treatment].
    Pechère JC; Tancrède C
    Pathol Biol (Paris); 1969 Feb; 17(3):155-8. PubMed ID: 4892933
    [No Abstract]   [Full Text] [Related]  

  • 25. Fluorometric and microbiological assays for rifampicin and the determination of serum levels in the dog.
    Finkel JM; Pittillo RF; Mellett LB
    Chemotherapy; 1971; 16(6):380-8. PubMed ID: 5145010
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bioavailability of 2 different rifampicin preparations].
    Aronne Benach MT; Naranjo Cascante G
    Rev Clin Esp; 1980 Oct; 159(1):43-6. PubMed ID: 7008102
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of the enzyme induction by rifampicin on its presystemic metabolism.
    Loos U; Musch E; Jensen JC; Schwabe HK; Eichelbaum M
    Pharmacol Ther; 1987; 33(1):201-4. PubMed ID: 3628475
    [No Abstract]   [Full Text] [Related]  

  • 28. [Metabolism of rifampicin in the human body (1st report)].
    Nakagawa H; Sunahara S
    Kekkaku; 1973 May; 48(5):167-76. PubMed ID: 4732656
    [No Abstract]   [Full Text] [Related]  

  • 29. Bioavailability of rifampicin caplets (600 mg and 450 mg) in healthy Indonesian subjects.
    Ganiswarna SG; Wilmana PF; Setiabudy R; Ringoringo VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):60-4. PubMed ID: 3957493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A bioequivalence comparison of two formulations of rifampicin (300- vs 150-mg capsules): An open-label, randomized, two-treatment, two-way crossover study in healthy volunteers.
    Chik Z; Basu RC; Pendek R; Lee TC; Mohamed Z
    Clin Ther; 2010 Sep; 32(10):1822-31. PubMed ID: 21194606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial pyrogens of different origin and pharmacokinetics of rifampicin.
    Lavický J; Urbanová Z; Celeda L; Rasková H; Kvĕtina J; Vanĕcek J; Krecek J
    Arzneimittelforschung; 1987 Jun; 37(6):713-6. PubMed ID: 3663270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-induction of rifampicin metabolism in man.
    Immanuel C; Jayasankar K; Narayana AS; Sarma GR
    Indian J Med Res; 1985 Nov; 82():381-7. PubMed ID: 4093155
    [No Abstract]   [Full Text] [Related]  

  • 33. [Multicompartimental model for the study of drugs with high biliary excretion, used in the study of the kinetics of rifampicin in man].
    Acocella G; Pagani V; Nicolis FB
    Boll Chim Farm; 1972 Feb; 111(2):108-15. PubMed ID: 5045532
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical application of rifampicin to common infections (author's transl)].
    Nakagawa K; Watanabe K; Suzuki T
    Jpn J Antibiot; 1974 Apr; 27(2):69-72. PubMed ID: 4603394
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: Kinetics of rifampicin and desacetyl-rifampicin in plasma, bile, and urine in humans and the effect of repeated administrations.
    Acocella G; Segre G
    Acta Pharm Suec; 1974 Dec; 11(6):657-8. PubMed ID: 1136808
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacokinetics of rifampicin].
    Kohno H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jan; 25(1):32-7. PubMed ID: 3599578
    [No Abstract]   [Full Text] [Related]  

  • 37. [Rifampicin diffusion in non-infected human bone (author's transl)].
    Sirot J; Lopitaux R; Cluzel R; Delisle JJ; Sauvezie B
    Ann Microbiol (Paris); 1977; 128(2):229-36. PubMed ID: 931258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of blood concentration of rifampicin between administration before and after breakfast].
    Tsukamura M; Yokouchi J; Miwa T; Koike K
    Kekkaku; 1972 Apr; 47(4):69-73. PubMed ID: 5073928
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anti-mycobacterial activity of rifampicin].
    Gialdroni Grassi G
    G Ital Mal Torace; 1971; 25(2):77-88. PubMed ID: 5003253
    [No Abstract]   [Full Text] [Related]  

  • 40. Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.
    Holmes IB
    Int J Lepr Other Mycobact Dis; 1974; 42(3):289-96. PubMed ID: 4617716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.